nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—testicular cancer	0.000517	0.000517	CcSEcCtD
Sibutramine—Epistaxis—Epirubicin—testicular cancer	0.000517	0.000517	CcSEcCtD
Sibutramine—Sinusitis—Epirubicin—testicular cancer	0.000514	0.000514	CcSEcCtD
Sibutramine—Feeling abnormal—Etoposide—testicular cancer	0.000514	0.000514	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000513	0.000513	CcSEcCtD
Sibutramine—Nausea—Dactinomycin—testicular cancer	0.000512	0.000512	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—testicular cancer	0.00051	0.00051	CcSEcCtD
Sibutramine—Gastrointestinal pain—Etoposide—testicular cancer	0.00051	0.00051	CcSEcCtD
Sibutramine—Visual impairment—Methotrexate—testicular cancer	0.000506	0.000506	CcSEcCtD
Sibutramine—Vomiting—Ifosfamide—testicular cancer	0.000502	0.000502	CcSEcCtD
Sibutramine—Hypersensitivity—Cisplatin—testicular cancer	0.000501	0.000501	CcSEcCtD
Sibutramine—Bradycardia—Epirubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Sibutramine—Rash—Ifosfamide—testicular cancer	0.000498	0.000498	CcSEcCtD
Sibutramine—Dermatitis—Ifosfamide—testicular cancer	0.000497	0.000497	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000497	0.000497	CcSEcCtD
Sibutramine—Urticaria—Etoposide—testicular cancer	0.000495	0.000495	CcSEcCtD
Sibutramine—Haemoglobin—Epirubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Sibutramine—Rhinitis—Epirubicin—testicular cancer	0.000493	0.000493	CcSEcCtD
Sibutramine—Abdominal pain—Etoposide—testicular cancer	0.000493	0.000493	CcSEcCtD
Sibutramine—Body temperature increased—Etoposide—testicular cancer	0.000493	0.000493	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—testicular cancer	0.000493	0.000493	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—testicular cancer	0.000493	0.000493	CcSEcCtD
Sibutramine—Haemorrhage—Epirubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Sibutramine—Eye disorder—Methotrexate—testicular cancer	0.000491	0.000491	CcSEcCtD
Sibutramine—Tinnitus—Methotrexate—testicular cancer	0.00049	0.00049	CcSEcCtD
Sibutramine—Hypoaesthesia—Epirubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Sibutramine—Asthenia—Cisplatin—testicular cancer	0.000488	0.000488	CcSEcCtD
Sibutramine—Pharyngitis—Epirubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Sibutramine—Oedema peripheral—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Sibutramine—Angiopathy—Methotrexate—testicular cancer	0.000477	0.000477	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Sibutramine—Immune system disorder—Methotrexate—testicular cancer	0.000475	0.000475	CcSEcCtD
Sibutramine—Visual impairment—Epirubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Sibutramine—Chills—Methotrexate—testicular cancer	0.000471	0.000471	CcSEcCtD
Sibutramine—Nausea—Ifosfamide—testicular cancer	0.000469	0.000469	CcSEcCtD
Sibutramine—Diarrhoea—Cisplatin—testicular cancer	0.000465	0.000465	CcSEcCtD
Sibutramine—Alopecia—Methotrexate—testicular cancer	0.000464	0.000464	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—testicular cancer	0.000463	0.000463	CcSEcCtD
Sibutramine—Eye disorder—Epirubicin—testicular cancer	0.00046	0.00046	CcSEcCtD
Sibutramine—Hypersensitivity—Etoposide—testicular cancer	0.000459	0.000459	CcSEcCtD
Sibutramine—Tinnitus—Epirubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Sibutramine—Malnutrition—Methotrexate—testicular cancer	0.000457	0.000457	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—testicular cancer	0.000457	0.000457	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—testicular cancer	0.000456	0.000456	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—testicular cancer	0.000455	0.000455	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Sibutramine—Dysgeusia—Methotrexate—testicular cancer	0.000448	0.000448	CcSEcCtD
Sibutramine—Asthenia—Etoposide—testicular cancer	0.000447	0.000447	CcSEcCtD
Sibutramine—Angiopathy—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—testicular cancer	0.000444	0.000444	CcSEcCtD
Sibutramine—Back pain—Methotrexate—testicular cancer	0.000442	0.000442	CcSEcCtD
Sibutramine—Chills—Epirubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Sibutramine—Pruritus—Etoposide—testicular cancer	0.000441	0.000441	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—testicular cancer	0.000439	0.000439	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Sibutramine—Alopecia—Epirubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Sibutramine—Vomiting—Cisplatin—testicular cancer	0.000433	0.000433	CcSEcCtD
Sibutramine—Vision blurred—Methotrexate—testicular cancer	0.000431	0.000431	CcSEcCtD
Sibutramine—Rash—Cisplatin—testicular cancer	0.000429	0.000429	CcSEcCtD
Sibutramine—Dermatitis—Cisplatin—testicular cancer	0.000429	0.000429	CcSEcCtD
Sibutramine—Malnutrition—Epirubicin—testicular cancer	0.000428	0.000428	CcSEcCtD
Sibutramine—Diarrhoea—Etoposide—testicular cancer	0.000426	0.000426	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—testicular cancer	0.000425	0.000425	CcSEcCtD
Sibutramine—Ill-defined disorder—Methotrexate—testicular cancer	0.000424	0.000424	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Sibutramine—Anaemia—Methotrexate—testicular cancer	0.000423	0.000423	CcSEcCtD
Sibutramine—Flatulence—Epirubicin—testicular cancer	0.000422	0.000422	CcSEcCtD
Sibutramine—Tension—Epirubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Sibutramine—Nervousness—Epirubicin—testicular cancer	0.000416	0.000416	CcSEcCtD
Sibutramine—Back pain—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Sibutramine—Malaise—Methotrexate—testicular cancer	0.000413	0.000413	CcSEcCtD
Sibutramine—Dizziness—Etoposide—testicular cancer	0.000412	0.000412	CcSEcCtD
Sibutramine—Muscle spasms—Epirubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Sibutramine—Vertigo—Methotrexate—testicular cancer	0.000411	0.000411	CcSEcCtD
Sibutramine—Leukopenia—Methotrexate—testicular cancer	0.000409	0.000409	CcSEcCtD
Sibutramine—Chills—Doxorubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—testicular cancer	0.000406	0.000406	CcSEcCtD
Sibutramine—Nausea—Cisplatin—testicular cancer	0.000404	0.000404	CcSEcCtD
Sibutramine—Vision blurred—Epirubicin—testicular cancer	0.000403	0.000403	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—testicular cancer	0.000402	0.000402	CcSEcCtD
Sibutramine—Cough—Methotrexate—testicular cancer	0.000399	0.000399	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—testicular cancer	0.000397	0.000397	CcSEcCtD
Sibutramine—Convulsion—Methotrexate—testicular cancer	0.000396	0.000396	CcSEcCtD
Sibutramine—Vomiting—Etoposide—testicular cancer	0.000396	0.000396	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Sibutramine—Agitation—Epirubicin—testicular cancer	0.000393	0.000393	CcSEcCtD
Sibutramine—Rash—Etoposide—testicular cancer	0.000393	0.000393	CcSEcCtD
Sibutramine—Dermatitis—Etoposide—testicular cancer	0.000393	0.000393	CcSEcCtD
Sibutramine—Headache—Etoposide—testicular cancer	0.00039	0.00039	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Sibutramine—Arthralgia—Methotrexate—testicular cancer	0.000389	0.000389	CcSEcCtD
Sibutramine—Chest pain—Methotrexate—testicular cancer	0.000389	0.000389	CcSEcCtD
Sibutramine—Myalgia—Methotrexate—testicular cancer	0.000389	0.000389	CcSEcCtD
Sibutramine—Tension—Doxorubicin—testicular cancer	0.000389	0.000389	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Sibutramine—Malaise—Epirubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Sibutramine—Discomfort—Methotrexate—testicular cancer	0.000385	0.000385	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Sibutramine—Syncope—Epirubicin—testicular cancer	0.000384	0.000384	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—testicular cancer	0.000381	0.000381	CcSEcCtD
Sibutramine—Palpitations—Epirubicin—testicular cancer	0.000378	0.000378	CcSEcCtD
Sibutramine—Confusional state—Methotrexate—testicular cancer	0.000376	0.000376	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—testicular cancer	0.000376	0.000376	CcSEcCtD
Sibutramine—Cough—Epirubicin—testicular cancer	0.000374	0.000374	CcSEcCtD
Sibutramine—Anaphylactic shock—Methotrexate—testicular cancer	0.000373	0.000373	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—testicular cancer	0.000373	0.000373	CcSEcCtD
Sibutramine—Convulsion—Epirubicin—testicular cancer	0.000371	0.000371	CcSEcCtD
Sibutramine—Infection—Methotrexate—testicular cancer	0.000371	0.000371	CcSEcCtD
Sibutramine—Nausea—Etoposide—testicular cancer	0.00037	0.00037	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—testicular cancer	0.00037	0.00037	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000368	0.000368	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Sibutramine—Thrombocytopenia—Methotrexate—testicular cancer	0.000366	0.000366	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Sibutramine—Chest pain—Epirubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—testicular cancer	0.000363	0.000363	CcSEcCtD
Sibutramine—Skin disorder—Methotrexate—testicular cancer	0.000363	0.000363	CcSEcCtD
Sibutramine—Hyperhidrosis—Methotrexate—testicular cancer	0.000361	0.000361	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—testicular cancer	0.00036	0.00036	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Sibutramine—Anorexia—Methotrexate—testicular cancer	0.000356	0.000356	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—testicular cancer	0.000355	0.000355	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—testicular cancer	0.000355	0.000355	CcSEcCtD
Sibutramine—Confusional state—Epirubicin—testicular cancer	0.000352	0.000352	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—testicular cancer	0.00035	0.00035	CcSEcCtD
Sibutramine—Anaphylactic shock—Epirubicin—testicular cancer	0.000349	0.000349	CcSEcCtD
Sibutramine—Oedema—Epirubicin—testicular cancer	0.000349	0.000349	CcSEcCtD
Sibutramine—Hypotension—Methotrexate—testicular cancer	0.000349	0.000349	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—testicular cancer	0.000348	0.000348	CcSEcCtD
Sibutramine—Infection—Epirubicin—testicular cancer	0.000347	0.000347	CcSEcCtD
Sibutramine—Cough—Doxorubicin—testicular cancer	0.000346	0.000346	CcSEcCtD
Sibutramine—Shock—Epirubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—testicular cancer	0.000343	0.000343	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—testicular cancer	0.000342	0.000342	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—testicular cancer	0.000342	0.000342	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00034	0.00034	CcSEcCtD
Sibutramine—Skin disorder—Epirubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—testicular cancer	0.000338	0.000338	CcSEcCtD
Sibutramine—Insomnia—Methotrexate—testicular cancer	0.000338	0.000338	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—testicular cancer	0.000337	0.000337	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—testicular cancer	0.000337	0.000337	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—testicular cancer	0.000337	0.000337	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—testicular cancer	0.000336	0.000336	CcSEcCtD
Sibutramine—Paraesthesia—Methotrexate—testicular cancer	0.000335	0.000335	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—testicular cancer	0.000333	0.000333	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—testicular cancer	0.000333	0.000333	CcSEcCtD
Sibutramine—Dyspnoea—Methotrexate—testicular cancer	0.000333	0.000333	CcSEcCtD
Sibutramine—Somnolence—Methotrexate—testicular cancer	0.000332	0.000332	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—testicular cancer	0.00033	0.00033	CcSEcCtD
Sibutramine—Dyspepsia—Methotrexate—testicular cancer	0.000329	0.000329	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—testicular cancer	0.000326	0.000326	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—testicular cancer	0.000326	0.000326	CcSEcCtD
Sibutramine—Decreased appetite—Methotrexate—testicular cancer	0.000325	0.000325	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000323	0.000323	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—testicular cancer	0.000323	0.000323	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000322	0.000322	CcSEcCtD
Sibutramine—Infection—Doxorubicin—testicular cancer	0.000321	0.000321	CcSEcCtD
Sibutramine—Pain—Methotrexate—testicular cancer	0.000319	0.000319	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Sibutramine—Shock—Doxorubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—testicular cancer	0.000316	0.000316	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—testicular cancer	0.000315	0.000315	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—testicular cancer	0.000314	0.000314	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—testicular cancer	0.000314	0.000314	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000313	0.000313	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—testicular cancer	0.000311	0.000311	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—testicular cancer	0.000311	0.000311	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—testicular cancer	0.000308	0.000308	CcSEcCtD
Sibutramine—Feeling abnormal—Methotrexate—testicular cancer	0.000308	0.000308	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—testicular cancer	0.000308	0.000308	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000305	0.000305	CcSEcCtD
Sibutramine—Decreased appetite—Epirubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Sibutramine—Pain—Epirubicin—testicular cancer	0.000299	0.000299	CcSEcCtD
Sibutramine—Constipation—Epirubicin—testicular cancer	0.000299	0.000299	CcSEcCtD
Sibutramine—Urticaria—Methotrexate—testicular cancer	0.000297	0.000297	CcSEcCtD
Sibutramine—Body temperature increased—Methotrexate—testicular cancer	0.000295	0.000295	CcSEcCtD
Sibutramine—Abdominal pain—Methotrexate—testicular cancer	0.000295	0.000295	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000295	0.000295	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—testicular cancer	0.000292	0.000292	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—testicular cancer	0.00029	0.00029	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—testicular cancer	0.000287	0.000287	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—testicular cancer	0.000285	0.000285	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—testicular cancer	0.000281	0.000281	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000279	0.000279	CcSEcCtD
Sibutramine—Urticaria—Epirubicin—testicular cancer	0.000278	0.000278	CcSEcCtD
Sibutramine—Pain—Doxorubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Sibutramine—Abdominal pain—Epirubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Sibutramine—Hypersensitivity—Methotrexate—testicular cancer	0.000275	0.000275	CcSEcCtD
Sibutramine—Asthenia—Methotrexate—testicular cancer	0.000268	0.000268	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—testicular cancer	0.000266	0.000266	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000264	0.000264	CcSEcCtD
Sibutramine—Pruritus—Methotrexate—testicular cancer	0.000264	0.000264	CcSEcCtD
Sibutramine—Hypersensitivity—Epirubicin—testicular cancer	0.000257	0.000257	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—testicular cancer	0.000257	0.000257	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—testicular cancer	0.000256	0.000256	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—testicular cancer	0.000256	0.000256	CcSEcCtD
Sibutramine—Diarrhoea—Methotrexate—testicular cancer	0.000255	0.000255	CcSEcCtD
Sibutramine—Asthenia—Epirubicin—testicular cancer	0.000251	0.000251	CcSEcCtD
Sibutramine—Pruritus—Epirubicin—testicular cancer	0.000247	0.000247	CcSEcCtD
Sibutramine—Dizziness—Methotrexate—testicular cancer	0.000247	0.000247	CcSEcCtD
Sibutramine—Diarrhoea—Epirubicin—testicular cancer	0.000239	0.000239	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—testicular cancer	0.000238	0.000238	CcSEcCtD
Sibutramine—Vomiting—Methotrexate—testicular cancer	0.000237	0.000237	CcSEcCtD
Sibutramine—Rash—Methotrexate—testicular cancer	0.000235	0.000235	CcSEcCtD
Sibutramine—Dermatitis—Methotrexate—testicular cancer	0.000235	0.000235	CcSEcCtD
Sibutramine—Headache—Methotrexate—testicular cancer	0.000234	0.000234	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—testicular cancer	0.000232	0.000232	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—testicular cancer	0.000231	0.000231	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—testicular cancer	0.000229	0.000229	CcSEcCtD
Sibutramine—Vomiting—Epirubicin—testicular cancer	0.000222	0.000222	CcSEcCtD
Sibutramine—Nausea—Methotrexate—testicular cancer	0.000222	0.000222	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
Sibutramine—Rash—Epirubicin—testicular cancer	0.00022	0.00022	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—testicular cancer	0.00022	0.00022	CcSEcCtD
Sibutramine—Headache—Epirubicin—testicular cancer	0.000219	0.000219	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—testicular cancer	0.000214	0.000214	CcSEcCtD
Sibutramine—Nausea—Epirubicin—testicular cancer	0.000208	0.000208	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—testicular cancer	0.000206	0.000206	CcSEcCtD
Sibutramine—Rash—Doxorubicin—testicular cancer	0.000204	0.000204	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—testicular cancer	0.000204	0.000204	CcSEcCtD
Sibutramine—Headache—Doxorubicin—testicular cancer	0.000203	0.000203	CcSEcCtD
Sibutramine—Nausea—Doxorubicin—testicular cancer	0.000192	0.000192	CcSEcCtD
